Cantor Fitzgerald

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
星期四, 三月 23, 2023
Restore, Neoplasm, Food and Drug Administration, CDTX, Adenosine, Congress, Janssen Pharmaceuticals, Patent, Patient, Therapy, Food, Research, Panel, FDA, IND, Conference, Safety, 1836 U.S. Patent Office fire, February 13–17, 2021 North American winter storm, Biotechnology, ESMO, H3N2, Tavarua, Standard of care, Caspofungin, SAN, Escape Room, Johnson & Johnson, DFC, Wuxi, CMC, NDA, CD73, Viral disease, Cantor Fitzgerald, Respect, Treatment, Pharmaceutical industry, Security (finance), Vaccine, Cryptocurrency, Janssen, Melinta Therapeutics, Lancet, Fungemia

This approval enables Cidara to receive a $20.0 million regulatory milestone payment under the terms of our agreement with Melinta Therapeutics,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara.

Key Points: 
  • This approval enables Cidara to receive a $20.0 million regulatory milestone payment under the terms of our agreement with Melinta Therapeutics,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara.
  • In addition, we announced the nomination of our first oncology DFC candidate, CBO-212, and presented preclinical data at the ESMO-TAT conference.
  • We are currently conducting investigational new drug (IND)-enabling activities for CD421, which is an enhanced version of CBO-212.
  • The gross proceeds to Cidara from these offerings, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $19.5 million.

Electra Closes US$51 million Secured Convertible Note Offering and Cancels US$36 million of Convertible Notes due 2026

Retrieved on: 
星期二, 二月 14, 2023
EV, Electric Vehicles, Other Energy, Sustainability, Mining, Minerals, Batteries, Alternative Energy, Alternative Vehicles, Fuels, Energy, Technology, Automotive, Natural Resources, Environment, Public expenditure, TSX Venture Exchange, Indian stock exchange, Warrant, EDGAR, SEDAR, News, Sale, Engineering, Cantor Fitzgerald, Security (finance), Life insurance, Note

Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra”, or the “Company”) announced that it has closed its previously announced private placement offering (the “Note Offering”) of US$51 million principal amount of 8.99% senior secured convertible notes due February 2028 (the “Notes”).

Key Points: 
  • Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra”, or the “Company”) announced that it has closed its previously announced private placement offering (the “Note Offering”) of US$51 million principal amount of 8.99% senior secured convertible notes due February 2028 (the “Notes”).
  • As part of the transaction, the Company purchased and cancelled all of the outstanding approximately US$36 million principal amount of the Company’s existing 6.95% senior secured notes due 2026 (the “2026 Notes”) at par, plus accrued and unpaid interest through the date of the closing.
  • The Noteholders received an aggregate of 10,796,054 warrants to purchase Common Shares (“Warrants”) exercisable for five years at US$2.48 in connection with the Note Offering.
  • In addition, provided the Company is not listed on TSXV, certain price-based adjustment mechanisms will apply to the Notes and the Warrants.

Oppenheimer Announces Expansion of Investment Grade Fixed Income Sales Team

Retrieved on: 
星期二, 二月 7, 2023
MBA, Bond credit rating, Rest, Oppenheimer Holdings, Goldman Sachs, Debt, Fifth Third Bank, NYSE, Municipal bond, Cohen, Executive officer, Senior, Bear Stearns, Colgate University, Knowledge, David Cohen & Co. Warehouse, Carnegie Mellon University, Cantor Fitzgerald, BBVA, Structured product, Kidder, Peabody & Company, Security (finance), Management, New York University, Boston College

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the continued expansion of its Investment Grade desk with the additions of Perren Thomas, Dennis Megley and Mike Henneberry. Each will serve as Managing Directors on the Investment Grade Sales team in New York and report to Katie Lucas, Managing Director, and Head of Investment Grade Sales.

Key Points: 
  • Each will serve as Managing Directors on the Investment Grade Sales team in New York and report to Katie Lucas, Managing Director, and Head of Investment Grade Sales.
  • Peter Albano, Global Head of Fixed Income at Oppenheimer, said, "We are delighted to welcome Perren, Dennis and Mike to the team.
  • These Investment Grade sales hires follow the recruitments of Managing Directors Si Lund (High Yield Sales), John Covello (Investment Grade Trading), Chris O'Connor (Debt Syndicate), Peter Overton (Short-term Trading), Ed Murphy (Municipal Bond Trading), Jose Puell (Emerging Markets Sales) and Russ Mueller (Structured Product Trading).
  • Mr. Thomas joins Oppenheimer with nearly two decades of experience in fixed income sales.

Vesta Taps Shimon Steinmetz as Chief Financial Officer

Retrieved on: 
星期二, 一月 31, 2023
MBA, CFO, Yeshiva University, Salomon Brothers, Finjan Holdings, Goldman Sachs, Shim, David G. Booth, Fraud, Business, University, China Merchants Group, Alvarez, Alvarez and Marsal, Growth, Steinmetz, Cantor Fitzgerald, Management, Renewable energy, Vesta

ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Vesta, a leading global transaction guarantee platform for online purchases, today announced the hiring of corporate transformation leader, Shimon Steinmetz, as Chief Financial Officer.

Key Points: 
  • ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Vesta, a leading global transaction guarantee platform for online purchases, today announced the hiring of corporate transformation leader, Shimon Steinmetz, as Chief Financial Officer.
  • Steinmetz brings over 20 years of experience partnering with management teams and private equity investors to boost operational performance and maximize stakeholder value.
  • As CFO, Steinmetz will lead Vesta's global finance organization and activities including performance improvement, financial operations, corporate development, investor sourcing, technology transformation, stakeholder management, and more.
  • "I am excited to join a company that's working to help businesses grow and succeed worldwide by eliminating fraud and increasing approval rates," said Shimon Steinmetz, CFO of Vesta.

Vesta Taps Shimon Steinmetz as Chief Financial Officer

Retrieved on: 
星期二, 一月 31, 2023
MBA, CFO, Yeshiva University, Salomon Brothers, Finjan Holdings, Goldman Sachs, Shim, David G. Booth, Fraud, Business, University, China Merchants Group, Alvarez, Alvarez and Marsal, Growth, Steinmetz, Cantor Fitzgerald, Management, Renewable energy, Vesta

ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Vesta, a leading global transaction guarantee platform for online purchases, today announced the hiring of corporate transformation leader, Shimon Steinmetz, as Chief Financial Officer.

Key Points: 
  • ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Vesta, a leading global transaction guarantee platform for online purchases, today announced the hiring of corporate transformation leader, Shimon Steinmetz, as Chief Financial Officer.
  • Steinmetz brings over 20 years of experience partnering with management teams and private equity investors to boost operational performance and maximize stakeholder value.
  • As CFO, Steinmetz will lead Vesta's global finance organization and activities including performance improvement, financial operations, corporate development, investor sourcing, technology transformation, stakeholder management, and more.
  • "I am excited to join a company that's working to help businesses grow and succeed worldwide by eliminating fraud and increasing approval rates," said Shimon Steinmetz, CFO of Vesta.

Zefiro Methane Appoints Tina Reine as Chief Commercial Officer

Retrieved on: 
星期四, 一月 12, 2023
Carbon, Business administration, News, METHANE, Master, CSE, Parliament, Environment, Master of Business Administration, CCO, United, NextEra Energy, Cantor Fitzgerald, Policy, Columbia Business School, SEDAR, Canadian Securities Exchange, Biophysical environment, MBA, USD, J. P. Morgan, Registry, Bank

VANCOUVER, British Columbia, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that Tina Reine has been appointed Chief Commercial Officer (“CCO”) of Zefiro, which has applied to have its common shares trade on the Canadian Securities Exchange (“CSE”). Listing is subject to receipt of conditional listing approval from the CSE and fulfilling all of the CSE’s requirements. Building upon an accomplished career in finance and the environmental markets, Ms. Reine will primarily be responsible for optimizing the Company’s earnings from carbon offsets earned through the completion of orphaned and abandoned wells located throughout the United States. Ms. Reine is also highly versed in the Environmental, Social, and Governance (“ESG”) aspects of carbon offsets, which can enhance their value proposition for corporate and institutional purchasers.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that Tina Reine has been appointed Chief Commercial Officer (“CCO”) of Zefiro, which has applied to have its common shares trade on the Canadian Securities Exchange (“CSE”).
  • As Director of Carbon Markets at World Kinect Energy Services , Ms. Reine was responsible for both structuring deals and origination.
  • Ms. Reine started her environmental markets career in London at Cantor Fitzgerald ’s Environmental Markets group in 2007, selling forward contracts on carbon offsets.
  • Regarding her appointment as CCO of Zefiro, Ms. Reine commented, “Carbon offsets are more relevant than ever as an instrument for neutralizing emissions to help save the environment.

McManus Joins SWBC Investment Company as Senior Vice President - Private Markets

Retrieved on: 
星期二, 一月 10, 2023
Credit Suisse, Partnership, Gary Barnett (real estate developer), Semper Fidelis (march), Lacrosse ball, Market share, Real, Swedish Infantry Officers' College, FINRA, VC, Lacrosse, SAN, Venture capital, McManus, Face, SWBC, Real estate, Bear Stearns, First lieutenant, Radar, Cantor Fitzgerald, Providence College, Senior, 3rd Battalion, 24th Marines, Management

SAN ANTONIO, Jan. 10, 2023 /PRNewswire/ -- SWBC Investment Company is excited to announce that Chris McManus has joined the company as Senior Vice President – Private Markets.

Key Points: 
  • SAN ANTONIO, Jan. 10, 2023 /PRNewswire/ -- SWBC Investment Company is excited to announce that Chris McManus has joined the company as Senior Vice President – Private Markets.
  • Reporting directly to the company's CEO, John Tuohy, McManus will also be responsible for driving the fundraising, investor relations, and product development across SWBC's private markets business in the Americas.
  • Since its inception, SWBC Investment Co. has empowered investors with unique offerings to help develop a balanced approach to their investment goals.
  • "One of the biggest challenges that investors face in today's market is the search for income and direct access to the private markets," said Chris McManus, Senior Vice President – Private Markets.

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

Retrieved on: 
星期四, 十二月 22, 2022
CET, Register, Park Avenue, Obstructive sleep apnea, OSA, Registration statement, ATM, USD, Form, Sale, Prospectus, Cantor, Cantor Fitzgerald, Mont-Saint-Guibert, Security (finance), Euronext

Once declared effective by the SEC, the Registration Statement would permit the Company to sell, from time to time, up to $200 million in aggregate value of its common stock, preferred stock, debt securities, warrants, and/or units.

Key Points: 
  • Once declared effective by the SEC, the Registration Statement would permit the Company to sell, from time to time, up to $200 million in aggregate value of its common stock, preferred stock, debt securities, warrants, and/or units.
  • The Registration Statement is intended to provide the Company with flexibility to access additional capital when market conditions are appropriate.
  • The ATM offering is being made only by means of a prospectus included within the Registration Statement.
  • These securities may not be sold nor may offers to buy these securities be accepted prior to the time the Registration Statement becomes effective.

EQS-News: What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers

Retrieved on: 
星期日, 十二月 18, 2022
Conference, Novik, The Jerusalem Post, Cell, CAR, Mortality, Annual report, Degenerative disease, Animal, Theodor Schwann, Advertising, Partnership, Security (finance), Marketing, Sepsis, Safety, Cancer, Cantor Fitzgerald, Cartilage, Interview, Risk, Human, Joint, Pfizer, Destiny, COGS, Immune system, Research, Blood, COVID-19, Spinal cord injury, Patient, Medical imaging, Vaccine, Medical device, Pharmaceutical industry, EU

Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds.

Key Points: 
  • Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds.
  • Because of the wide applications of this technology, the global cell therapy market is growing.
  • In particular, Enlivex Therapeutics says it is already looking into the future of cell therapy in oncology.
  • Apart from T-cell therapy, another area of research in cell therapy is CAR-T cell therapy.

EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts 

Retrieved on: 
星期二, 十一月 29, 2022
Benchmark, Financial Times, Rockefeller Foundation, Research, EF, Biotechnology, Associate, Secondary research, AMA, Doctor of Philosophy, Johns Hopkins University, Wall Street, University of California, AIM, Health, Virginia BioTechnology Research Park, Baylor University, Raymond James Financial, KWG, Engineering, Rockefeller, The Wall Street Journal, University, Roth Capital Partners, Health care, BS, Guggenheim Partners, Rockefeller University, Cantor Fitzgerald, MD, Senior, Materials science, Agency for Healthcare Research and Quality, Lehman, EF Hutton, Pharmaceutical industry, Management, Guggenheim, Neuroscience

New York, NY, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --EF Hutton, division of Benchmark Investments LLC (EF Hutton), today announced a series of strategic hires enhancing the companys Healthcare Equity Research Department.

Key Points: 
  • New York, NY, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --EF Hutton, division of Benchmark Investments LLC (EF Hutton), today announced a series of strategic hires enhancing the companys Healthcare Equity Research Department.
  • Tony Butler, Senior Managing Director, Elemer Piros, Managing Director, Fozia Ahmed, Associate and Tashdid Hasan, Associate, will join the team of Healthcare Equity Research Analysts at EF Hutton.
  • Joseph T. Rallo, CEO of EF Hutton, stated, Four major healthcare appointments demonstrates that EF Hutton is committed to bringing on top tier talent.
  • Tony Butler, PhD, Senior Managing Director, joins EF Hutton with over 30 years of experience focusing on the pharmaceutical and biotechnology industry.